All listed pharmaceutical enterprises: how to divide 196 enterprises?

Source: bioprospecting 2015-4-24 is of great importance to the development of the whole Chinese pharmaceutical industry In recent years, there are several important things: 1 Fierce competition, large and small pharmaceutical factories The new version of GMP has been issued in 2009, namely good manufacturing practice With the promulgation of this new regulation, we have eliminated small and large unqualified pharmaceutical factories, reduced the competition pattern, improved the industry concentration and established the authority; 2 The national health insurance promoted by the medical reform has advantages and disadvantages On the one hand, it greatly expands the demand of the drug market on the whole; on the other hand, it restricts the price rise of counterfeit drugs and the bargaining power of the whole pharmaceutical enterprises on the whole; on the other hand, it restricts the price of counterfeit drugs At present, the efficacy of drugs independently developed by China is relatively limited, many of which are imitated by foreign countries (after the protection period, domestic pharmaceutical companies imitate), so it can be said that the level of Chinese pharmaceutical industry and the R & D capacity still need to be improved; then look at how many pharmaceutical companies are in the capital market of the whole A-share, the overall status of the industry and the overall situation of the industry As of April 22, 2015, there are 2672 listed companies in the great A-share market, of which 196 are in the pharmaceutical industry, accounting for 7.34%; the total market value of the city is 61.9 trillion, and the pharmaceutical industry is 3.08 trillion, accounting for 5.0%; according to the classification of Shenwan industry, the pharmaceutical and biological industry is subdivided into 6 There are two secondary industries, i.e traditional Chinese medicine, chemical pharmacy, biological products, pharmaceutical products, medical devices and medical services The specific distribution is as follows Obviously, traditional Chinese medicine and chemical pharmacy are the big brother, and the second industry accounts for about two-thirds of the world Take a look at the market value of each industry segment, it seems to be very stimulating As you can see, the leader of each industry segment is a very familiar enterprise According to the current pace, it is not impossible for the pharmaceutical industry to generate a market value of 100 billion yuan, and a market value of 200 billion yuan For example, Hengrui medicine of tumor, Kangmei medicine of traditional Chinese medicine, Shanghai Laishi, Tianshili and Yunnan Baiyao all have certain core competitiveness in the industry, and the trend is booming